In conclusion, by validating its systematic biological function, molecular mechanism, and clinical applications, we have demonstrated that CPNE3 promotes GC cell proliferation, metastasis, and chemoresistance by acting as an oncogene in a YAP1-partially-dependent manner. Here, YAP1 is linked to gastric cancer.